Your session is about to expire
← Back to Search
Setrusumab vs Bisphosphonates for Osteogenesis Imperfecta (Cosmic Trial)
Cosmic Trial Summary
This trial compares the effectiveness of two treatments for reducing fractures in children, Setrusumab and IV-BP.
Cosmic Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Cosmic Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a history of spinal nerve passage narrowing not caused by scoliosis.I cannot use IV bisphosphonates as decided by my doctor.I do not have severe kidney disease or disorders affecting my bones.I have symptoms of Chiari malformation or basilar invagination, with no unstable neurologic diseases in the past 2 years.My Osteogenesis Imperfecta (Types I, III, IV) is confirmed by a genetic test.My kidney function is low, with an eGFR of 35 mL/min/1.73 m2 or less.I have had cancer in my bones or bone metastases before.I have a history of heart or blood vessel diseases.I am allergic to setrusumab or its ingredients.My vitamin D level is at least 20 ng/mL, or I've taken supplements to reach this.I have had one or more bone fractures in the last 2 years.I have or am receiving IV treatment for brittle bone disease.I have a bone condition that is not OI but causes deformity or higher fracture risk.I have never taken growth hormone, denosumab, anti-sclerostin antibody, or similar medications affecting bones.My blood calcium levels are low after fasting for at least 4 hours.I have undergone external radiation therapy before.I am between 2 and 6 years old.
- Group 1: Intravenous Bisphosphonates (IV-BP) -> Setrusumab
- Group 2: Setrusumab
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the age requirement for participation in this clinical trial above or below thirty years?
"In accordance with the study prerequisites, participants need to be between 2 and 4 years of age in order to qualify."
Has Setrusumab attained regulatory clearance from the FDA?
"There is existing evidence demonstrating the safety of Setrusumab, leading to a score of 3 on our team's scale. This medication has been through Phase 3 trials and numerous studies have backed up its efficacy."
Are there still opportunities for individuals to take part in this trial?
"Verified. According to clinicaltrials.gov, this medical trial is currently recruiting participants. This study was initially posted on May 1st 2023 and has been modified as recently as May 5th 2023. It needs 66 patients from a single site for the experiment to be successful."
Could I be a potential subject for this clinical experiment?
"Candidates wishing to be considered for this clinical trial must possess osteogenesis imperfecta and be aged between 2 and 4 years old. 66 patients are anticipated to take part in the study."
Could you tell me how many individuals are being admitted to this experiment?
"Affirmative. According to the records available on clinicaltrials.gov, this medical trial is presently enrolling participants; it was initially advertised on 5th May 2023 and recently updated in the same month. This research project will include 66 individuals from a single site."
Share this study with friends
Copy Link
Messenger